GBT Stock: Higher Prices Are Now in Development
It didn't take long to vindicate my bullish stance on Global Blood Therapeutics Inc (NASDAQ:GBT) stock, because the same day my report, "Eyeing These Global Blood Therapeutics Stock Price Developments," was published, GBT stock appreciated to the tune of 19.07% on the heels of receiving an FDA breakthrough therapy designation for "Voxelotor" for the treatment of Sickle cell disease.
This FDA designation was the catalyst that sent the Global Blood Therapeutics stock price higher, but my.
Den vollständigen Artikel lesen ...
It didn't take long to vindicate my bullish stance on Global Blood Therapeutics Inc (NASDAQ:GBT) stock, because the same day my report, "Eyeing These Global Blood Therapeutics Stock Price Developments," was published, GBT stock appreciated to the tune of 19.07% on the heels of receiving an FDA breakthrough therapy designation for "Voxelotor" for the treatment of Sickle cell disease.
This FDA designation was the catalyst that sent the Global Blood Therapeutics stock price higher, but my.
Den vollständigen Artikel lesen ...